Clinical Trial Detail

NCT ID NCT02844439
Title Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kadmon Corporation, LLC
Indications

glioblastoma multiforme

Therapies

Tesevatinib

Age Groups: adult senior

No variant requirements are available.